Pharmacolog appoints Chief Operating Officer
New York Presbyterian signs additional agreement
Shipment of first DrugLog® unit to B. Braun Spain
Pharmacolog expands into China with Codonics
Warrants of series TO1 were subscribed to approximately 94.1 percent and Pharmacolog i Uppsala AB (publ) receives approximately SEK 21.4 million
TriHealth Good Samaritan Hospital choose WasteLog®
Members of the board of directors and the management team of Pharmacolog exercise all held warrants of series TO1 for approximately SEK 1.47 million
The last day of trading with the warrants of series TO1 in Pharmacolog i Uppsala AB (publ) is August 13, 2021
Interim report January – June 2021
The exercise period for warrants of series TO1 begins today
The website uses necessary cookies to ensure the website functions properly. You can also choose to consent to cookies for statistical purposes.
Search
By requesting this documentation I agree to the terms in Pharmacologs privacy policy
